Bioethics of somatic gene therapy : what do we know so far?

2023
journal article
article
7
dc.abstract.enObjective: To provide a systematic overview of bioethical debate on somatic gene therapy as documented in the scientific literature. Methods: We performed a systematic review of reasons, following Strech and Sofaer approach, which is a method to systematically identify and classify arguments (reasons) used in the scientific literature. We identified 217 eligible publications retrieved from PubMed, Lilacs, PhilPapers, and Google Scholar. A meta-synthesis was performed to analyze the data. Results: We extracted 189 arguments. Arguments were grouped into 23 categories. Twelve categories were classified as research-related, including the risk/benefit ratio, priorities and limits, informed consent, review, and monitoring. Eleven were classified as society-related, including population impact, human identity, public perception, human health. Conclusion: Our study provides a database of existing challenges and arguments of somatic gene therapy and may serve as the basis of normative analysis. By presenting collected arguments, we contribute to the discussion about the ethics and social dimensions of somatic gene therapy.
dc.affiliationWydział Nauk o Zdrowiu : Instytut Pielęgniarstwa i Położnictwapl
dc.cm.date2023-10-04T13:17:43Z
dc.cm.id113295pl
dc.cm.idOmegaUJCMe69526eb3cad433486043e83ca596775pl
dc.contributor.authorBuedo, Paola - 446650 pl
dc.contributor.authorBianchini, Alahipl
dc.contributor.authorKlaś, Katarzyna - 230288 pl
dc.contributor.authorWaligóra, Marcin - 145433 pl
dc.date.accession2023-10-03pl
dc.date.accessioned2023-10-04T13:17:43Z
dc.date.available2023-10-04T13:17:43Z
dc.date.issued2023pl
dc.date.openaccess0
dc.description.accesstimew momencie opublikowania
dc.description.additionalOnline First 2023-08-29pl
dc.description.number10pl
dc.description.physical1355-1365pl
dc.description.physical
dc.description.versionostateczna wersja wydawcy
dc.description.volume39pl
dc.identifier.doi10.1080/03007995.2023.2257600pl
dc.identifier.eissn1473-4877pl
dc.identifier.issn0300-7995pl
dc.identifier.urihttps://ruj.uj.edu.pl/xmlui/handle/item/320479
dc.identifier.weblinkhttps://www.tandfonline.com/doi/full/10.1080/03007995.2023.2257600pl
dc.languageengpl
dc.language.containerengpl
dc.pbn.affiliationDziedzina nauk medycznych i nauk o zdrowiu : nauki o zdrowiu
dc.rightsUdzielam licencji. Uznanie autorstwa 4.0 Międzynarodowa
dc.rights.licenceCC-BY
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/legalcode.pl
dc.share.typeOtwarte czasopismo
dc.source.integratorfalse
dc.subject.engene therapy
dc.subject.ensomatic cells
dc.subject.enbioethics
dc.subject.enrisk assessment
dc.subject.enethics
dc.subject.ensocial impact
dc.subtypeArticlepl
dc.titleBioethics of somatic gene therapy : what do we know so far?pl
dc.title.journalCurrent Medical Research and Opinionpl
dc.typeJournalArticlepl
dspace.entity.typePublication
dc.abstract.en
Objective: To provide a systematic overview of bioethical debate on somatic gene therapy as documented in the scientific literature. Methods: We performed a systematic review of reasons, following Strech and Sofaer approach, which is a method to systematically identify and classify arguments (reasons) used in the scientific literature. We identified 217 eligible publications retrieved from PubMed, Lilacs, PhilPapers, and Google Scholar. A meta-synthesis was performed to analyze the data. Results: We extracted 189 arguments. Arguments were grouped into 23 categories. Twelve categories were classified as research-related, including the risk/benefit ratio, priorities and limits, informed consent, review, and monitoring. Eleven were classified as society-related, including population impact, human identity, public perception, human health. Conclusion: Our study provides a database of existing challenges and arguments of somatic gene therapy and may serve as the basis of normative analysis. By presenting collected arguments, we contribute to the discussion about the ethics and social dimensions of somatic gene therapy.
dc.affiliationpl
Wydział Nauk o Zdrowiu : Instytut Pielęgniarstwa i Położnictwa
dc.cm.date
2023-10-04T13:17:43Z
dc.cm.idpl
113295
dc.cm.idOmegapl
UJCMe69526eb3cad433486043e83ca596775
dc.contributor.authorpl
Buedo, Paola - 446650
dc.contributor.authorpl
Bianchini, Alahi
dc.contributor.authorpl
Klaś, Katarzyna - 230288
dc.contributor.authorpl
Waligóra, Marcin - 145433
dc.date.accessionpl
2023-10-03
dc.date.accessioned
2023-10-04T13:17:43Z
dc.date.available
2023-10-04T13:17:43Z
dc.date.issuedpl
2023
dc.date.openaccess
0
dc.description.accesstime
w momencie opublikowania
dc.description.additionalpl
Online First 2023-08-29
dc.description.numberpl
10
dc.description.physicalpl
1355-1365
dc.description.physical
dc.description.version
ostateczna wersja wydawcy
dc.description.volumepl
39
dc.identifier.doipl
10.1080/03007995.2023.2257600
dc.identifier.eissnpl
1473-4877
dc.identifier.issnpl
0300-7995
dc.identifier.uri
https://ruj.uj.edu.pl/xmlui/handle/item/320479
dc.identifier.weblinkpl
https://www.tandfonline.com/doi/full/10.1080/03007995.2023.2257600
dc.languagepl
eng
dc.language.containerpl
eng
dc.pbn.affiliation
Dziedzina nauk medycznych i nauk o zdrowiu : nauki o zdrowiu
dc.rights
Udzielam licencji. Uznanie autorstwa 4.0 Międzynarodowa
dc.rights.licence
CC-BY
dc.rights.uri
http://creativecommons.org/licenses/by/4.0/legalcode.pl
dc.share.type
Otwarte czasopismo
dc.source.integrator
false
dc.subject.en
gene therapy
dc.subject.en
somatic cells
dc.subject.en
bioethics
dc.subject.en
risk assessment
dc.subject.en
ethics
dc.subject.en
social impact
dc.subtypepl
Article
dc.titlepl
Bioethics of somatic gene therapy : what do we know so far?
dc.title.journalpl
Current Medical Research and Opinion
dc.typepl
JournalArticle
dspace.entity.type
Publication
Affiliations

* The migration of download and view statistics prior to the date of April 8, 2024 is in progress.

Views
15
Views per month
Views per city
Krakow
9
Beijing
1
Munich
1
Downloads
buedo_et-al_bioethics_of_somatic_gene_therapy_2023.pdf
81